The global market for Transdermal Patch was valued at US$ 7287 million in the year 2024 and is projected to reach a revised size of US$ 9302 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Transdermal Patch Market Overview
1.1 Product Definition
1.2 Transdermal Patch by Type
1.2.1 Global Transdermal Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Patch by Application
1.3.1 Global Transdermal Patch Market Value by Application (2024 VS 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Patch Revenue 2020-2031
1.4.2 Global Transdermal Patch Sales 2020-2031
1.4.3 Global Transdermal Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Transdermal Patch Market Competition by Manufacturers
2.1 Global Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Transdermal Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Patch, Product Type & Application
2.7 Global Key Manufacturers of Transdermal Patch, Date of Enter into This Industry
2.8 Global Transdermal Patch Market Competitive Situation and Trends
2.8.1 Global Transdermal Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Transdermal Patch Players Market Share by Revenue
2.8.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transdermal Patch Market Scenario by Region
3.1 Global Transdermal Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Transdermal Patch Sales by Region: 2020-2031
3.2.1 Global Transdermal Patch Sales by Region: 2020-2025
3.2.2 Global Transdermal Patch Sales by Region: 2026-2031
3.3 Global Transdermal Patch Revenue by Region: 2020-2031
3.3.1 Global Transdermal Patch Revenue by Region: 2020-2025
3.3.2 Global Transdermal Patch Revenue by Region: 2026-2031
3.4 North America Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Transdermal Patch Sales by Country (2020-2031)
3.4.3 North America Transdermal Patch Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Transdermal Patch Sales by Country (2020-2031)
3.5.3 Europe Transdermal Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Transdermal Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Transdermal Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Transdermal Patch Sales by Country (2020-2031)
3.7.3 Latin America Transdermal Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Transdermal Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Transdermal Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Patch Sales by Type (2020-2031)
4.1.1 Global Transdermal Patch Sales by Type (2020-2025)
4.1.2 Global Transdermal Patch Sales by Type (2026-2031)
4.1.3 Global Transdermal Patch Sales Market Share by Type (2020-2031)
4.2 Global Transdermal Patch Revenue by Type (2020-2031)
4.2.1 Global Transdermal Patch Revenue by Type (2020-2025)
4.2.2 Global Transdermal Patch Revenue by Type (2026-2031)
4.2.3 Global Transdermal Patch Revenue Market Share by Type (2020-2031)
4.3 Global Transdermal Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Transdermal Patch Sales by Application (2020-2031)
5.1.1 Global Transdermal Patch Sales by Application (2020-2025)
5.1.2 Global Transdermal Patch Sales by Application (2026-2031)
5.1.3 Global Transdermal Patch Sales Market Share by Application (2020-2031)
5.2 Global Transdermal Patch Revenue by Application (2020-2031)
5.2.1 Global Transdermal Patch Revenue by Application (2020-2025)
5.2.2 Global Transdermal Patch Revenue by Application (2026-2031)
5.2.3 Global Transdermal Patch Revenue Market Share by Application (2020-2031)
5.3 Global Transdermal Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Company Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Transdermal Patch Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Company Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB Pharma Transdermal Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Transdermal Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Company Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.7.1 Nitto Denko Company Information
6.7.2 Nitto Denko Description and Business Overview
6.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nitto Denko Transdermal Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 ³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô
6.8.1 ³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô Company Information
6.8.2 ³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô Description and Business Overview
6.8.3 ³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô Transdermal Patch Product Portfolio
6.8.5 ³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Company Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 IBSA Group Transdermal Patch Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Transdermal Patch Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Company Information
6.11.2 Luye Pharma Group Description and Business Overview
6.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Company Information
6.12.2 Pfizer Description and Business Overview
6.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pfizer Transdermal Patch Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Company Information
6.13.2 Chattem Description and Business Overview
6.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chattem Transdermal Patch Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Company Information
6.14.2 Dr Reddy’s Laboratories Description and Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Company Information
6.15.2 Bayer Description and Business Overview
6.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bayer Transdermal Patch Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Company Information
6.16.2 Mundipharma Description and Business Overview
6.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Mundipharma Transdermal Patch Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Endo International
6.17.1 Endo International Company Information
6.17.2 Endo International Description and Business Overview
6.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Endo International Transdermal Patch Product Portfolio
6.17.5 Endo International Recent Developments/Updates
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Company Information
6.18.2 Beijing Tide Pharmaceutical Description and Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Patch Industry Chain Analysis
7.2 Transdermal Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Patch Production Mode & Process Analysis
7.4 Transdermal Patch Sales and Marketing
7.4.1 Transdermal Patch Sales Channels
7.4.2 Transdermal Patch Distributors
7.5 Transdermal Patch Customer Analysis
8 Transdermal Patch Market Dynamics
8.1 Transdermal Patch Industry Trends
8.2 Transdermal Patch Market Drivers
8.3 Transdermal Patch Market Challenges
8.4 Transdermal Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
³Ò°ùü²Ô±ð²Ô³Ù³ó²¹±ô
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Ìý
Ìý
*If Applicable.